Burger K N, van der Bijl P, van Meer G
Department of Cell Biology, Faculty of Medicine, Universiteit Utrecht, The Netherlands.
J Cell Biol. 1996 Apr;133(1):15-28. doi: 10.1083/jcb.133.1.15.
Glucosylceramide (GlcCer) is synthesized at the cytosolic surface of the Golgi complex while enzymes acting in late steps of glycosphingolipid biosynthesis have their active centers in the Golgi lumen. However, the topology of the "early" galactose-transferring enzymes is largely unknown. We used short-chain ceramides with either an 2-hydroxy fatty acid (HFA) or a normal fatty acid (NFA) to determine the topology of the galactosyltransferases involved in the formation of HFA- and NFA-galactosylceramide (GalCer), lactosylceramide (LacCer), and galabiosylceramide (Ga2Cer). Although the HFA-GalCer synthesizing activity colocalized with an ER marker, the other enzyme activities fractionated at the Golgi density of a sucrose gradient. In cell homogenates and permeabilized cells, newly synthesized short-chain GlcCer and GalCer were accessible to serum albumin, whereas LacCer and Ga2Cer were protected. From this and from the results obtained after protease treatment, and after interfering with UDP-Gal import into the Golgi, we conclude that (a) GlcCer and NFA-GalCer are synthesized in the cytosolic leaflet, while LacCer and Ga2Cer are synthesized in the lumenal leaflet of the Golgi. (b) HFA-GalCer is synthesized in the lumenal leaflet of the ER, but has rapid access to the cytosolic leaflet. (c) GlcCer, NFA-GalCer, and HFA-GalCer translocate from the cytosolic to the lumenal leaflet of the Golgi membrane. The transbilayer movement of GlcCer and NFA-GalCer in the Golgi complex is an absolute requirement for higher glycosphingolipid biosynthesis and for the cell surface expression of these monohexosyl sphingolipids.
葡糖神经酰胺(GlcCer)在高尔基体复合物的胞质表面合成,而参与糖鞘脂生物合成后期步骤的酶的活性中心位于高尔基体腔中。然而,“早期”半乳糖转移酶的拓扑结构在很大程度上尚不清楚。我们使用带有2-羟基脂肪酸(HFA)或正常脂肪酸(NFA)的短链神经酰胺来确定参与HFA-和NFA-半乳糖神经酰胺(GalCer)、乳糖神经酰胺(LacCer)和二半乳糖神经酰胺(Ga2Cer)形成的半乳糖转移酶的拓扑结构。尽管HFA-GalCer合成活性与内质网标记物共定位,但其他酶活性在蔗糖梯度的高尔基体密度处分级分离。在细胞匀浆和通透细胞中,新合成的短链GlcCer和GalCer可被血清白蛋白接近,而LacCer和Ga2Cer受到保护。基于此以及蛋白酶处理后和干扰UDP-Gal导入高尔基体后获得的结果,我们得出以下结论:(a)GlcCer和NFA-GalCer在胞质小叶中合成,而LacCer和Ga2Cer在高尔基体的腔小叶中合成。(b)HFA-GalCer在内质网的腔小叶中合成,但能快速进入胞质小叶。(c)GlcCer、NFA-GalCer和HFA-GalCer从高尔基体膜的胞质小叶转运至腔小叶。GlcCer和NFA-GalCer在高尔基体复合物中的跨双层运动是更高糖鞘脂生物合成以及这些单己糖鞘脂细胞表面表达的绝对必要条件。